359 related articles for article (PubMed ID: 31744165)
1. Exploring a New Natural Treating Agent for Primary Hypertension: Recent Findings and Forthcoming Perspectives.
Lin SR; Lin SY; Chen CC; Fu YS; Weng CF
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31744165
[TBL] [Abstract][Full Text] [Related]
2. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
3. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
5. The Role of Beta-Blockers in the Treatment of Hypertension.
Cruickshank JM
Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
[TBL] [Abstract][Full Text] [Related]
6. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
7. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
8. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
[TBL] [Abstract][Full Text] [Related]
9. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
10. Development and trends in the drug treatment of essential hypertension.
van Zwieten PA
J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
[TBL] [Abstract][Full Text] [Related]
11. Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options.
Lüders S
Drugs; 2007; 67(7):955-63. PubMed ID: 17488141
[TBL] [Abstract][Full Text] [Related]
12. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
13. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
14. Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.
Drapala A; Sikora M; Ufnal M
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):250-8. PubMed ID: 25037529
[TBL] [Abstract][Full Text] [Related]
15. Aliskiren: renin inhibitor for hypertension management.
Cheng JW
Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
[TBL] [Abstract][Full Text] [Related]
16. Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
Lin YC; Lin JW; Wu MS; Chen KC; Peng CC; Kang YN
PLoS One; 2017; 12(12):e0188975. PubMed ID: 29240784
[TBL] [Abstract][Full Text] [Related]
17. K
Poulsen SB; Fenton RA
J Physiol; 2019 Sep; 597(17):4451-4464. PubMed ID: 31294465
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin II AT1 receptor blockers in the treatment of arterial hypertension.
Contreras F; de la Parte MA; Cabrera J; Ospino N; Israili ZH; Velasco M
Am J Ther; 2003; 10(6):401-8. PubMed ID: 14624277
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
